Nektar Therapeutics: latest news - GoINPHARMA
Tuesday, 11 December 2018 - 23:34

Nektar Therapeutics

Bristol-Myers Squibb enters into $3.6bn agreement with Nektar Therapeutics

Bristol-Myers Squibb is pursuing M&A again: yesterday, in the late evening, it announced an agreement with Nektar Therapeutics, expanding the existing strategic collaboration agreement signed in 2016 by the two companies for the scientific and commercial development of immunotherapy NKTR-214…